Clinical Trial Update: SARS-CoV-2 Human Challenge Characterisation Study [NA]

View source ↗

Summary

Imperial College London's SARS-CoV-2 human challenge characterization study has completed and posted its results. The study centers on characterizing the SARS-C…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syndrome

Snippet

Sponsor: Imperial College London | Conditions: Covid19, SARS-CoV Infection | NA | Status: COMPLETED | Results posted: 2025-05-16